Crossmark Global Holdings Inc. reduced its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 7.5% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 16,593 shares of the company’s stock after selling 1,352 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Henry Schein were worth $1,205,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Commerce Bank lifted its position in shares of Henry Schein by 5.5% in the first quarter. Commerce Bank now owns 14,473 shares of the company’s stock valued at $973,000 after acquiring an additional 760 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its position in shares of Henry Schein by 1.8% in the second quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 46,794 shares of the company’s stock valued at $3,399,000 after acquiring an additional 846 shares in the last quarter. BB&T Securities LLC lifted its position in shares of Henry Schein by 26.8% in the first quarter. BB&T Securities LLC now owns 4,676 shares of the company’s stock valued at $314,000 after acquiring an additional 988 shares in the last quarter. Gabelli Funds LLC lifted its position in shares of Henry Schein by 0.3% in the first quarter. Gabelli Funds LLC now owns 332,300 shares of the company’s stock valued at $22,334,000 after acquiring an additional 1,100 shares in the last quarter. Finally, Dupont Capital Management Corp lifted its position in shares of Henry Schein by 4.7% in the first quarter. Dupont Capital Management Corp now owns 25,620 shares of the company’s stock valued at $1,722,000 after acquiring an additional 1,148 shares in the last quarter.

Shares of Henry Schein stock opened at $78.53 on Friday. Henry Schein, Inc. has a one year low of $62.56 and a one year high of $89.34. The company has a market cap of $12.22 billion, a P/E ratio of 20.84, a P/E/G ratio of 2.18 and a beta of 1.00. The company has a current ratio of 1.29, a quick ratio of 0.74 and a debt-to-equity ratio of 0.34.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Monday, August 6th. The company reported $1.04 EPS for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.03. Henry Schein had a return on equity of 20.40% and a net margin of 3.15%. The firm had revenue of $3.33 billion for the quarter, compared to the consensus estimate of $3.31 billion. During the same quarter last year, the business posted $0.88 earnings per share. The firm’s revenue was up 8.7% compared to the same quarter last year. research analysts predict that Henry Schein, Inc. will post 4.11 earnings per share for the current year.

Several equities analysts have recently weighed in on the company. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, May 10th. BidaskClub upgraded Henry Schein from a “hold” rating to a “buy” rating in a research report on Thursday, July 26th. Stifel Nicolaus raised their target price on Henry Schein from $76.00 to $81.00 and gave the company a “hold” rating in a research report on Tuesday. Robert W. Baird raised their target price on Henry Schein from $83.00 to $90.00 and gave the company an “outperform” rating in a research report on Tuesday. Finally, Craig Hallum raised their target price on Henry Schein from $83.00 to $96.00 and gave the company a “buy” rating in a research report on Tuesday. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and nine have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $84.11.

In other Henry Schein news, EVP Mark E. Mlotek sold 10,359 shares of the firm’s stock in a transaction on Tuesday, June 12th. The stock was sold at an average price of $72.73, for a total transaction of $753,410.07. Following the completion of the sale, the executive vice president now owns 79,506 shares of the company’s stock, valued at $5,782,471.38. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Paul Brons sold 4,822 shares of the firm’s stock in a transaction on Monday, June 11th. The stock was sold at an average price of $72.93, for a total value of $351,668.46. Following the sale, the director now directly owns 20,889 shares of the company’s stock, valued at approximately $1,523,434.77. The disclosure for this sale can be found here. Company insiders own 1.15% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More: Market Capitalization in the Stock Market

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.